Inpatient Glycemic Control

ADA Inpatient Glycemic Control

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/61552

Contents of this Issue

Navigation

Page 1 of 11

Key Points ÎDiabetes is a chronic illness that requires continuing medical care and ongoing patient self-management education and support to prevent acute complications and to reduce the risk of long-term complications. ÎDiabetes care is complex and requires that many issues, beyond glycemic control, be addressed. Diagnosis and Assessment* Classification of Diabetes The classification of diabetes includes four clinical classes: ÎType 1 diabetes > Results from β-cell destruction, usually leading to absolute insulin deficiency ÎType 2 diabetes > Results from a progressive insulin secretory defect on the background of insulin resistance ÎOther specific types of diabetes due to other causes, eg, genetic defects in β-cell function, genetic defects in insulin action, diseases of the exocrine pancreas (such as cystic fibrosis), and drug- or chemical-induced (such as in the treatment of HIV/AIDS or after organ transplantation) ÎGestational diabetes mellitus (GDM) > Diabetes diagnosed during pregnancy that is not clearly overt diabetes Testing for Diabetes in Asymptomatic Patients ÎTesting to detect type 2 diabetes and assess risk for future diabetes in asymptomatic people should be considered in adults of any age who are overweight or obese (body mass index [BMI] ≥ 25 kg/m2 ) and who have one or more additional risk factors for diabetes (Table 2). In those without these risk factors, testing should begin at age 45 years. (B) ÎIf tests are normal, repeat testing carried out at least at 3-year intervals is reasonable. (E) ÎTo test for diabetes or to assess risk of future diabetes, glycohemoglobin (A1c), fasting plasma glucose (FPG), or 2-h 75-g oral glucose tolerance test (OGTT) is appropriate. (B) ÎIn those identified with increased risk for future diabetes, identify and, if appropriate, treat other cardiovascular disease (CVD) risk factors. (B) * To be used with appropriate care setting and patient type.

Articles in this issue

Archives of this issue

view archives of Inpatient Glycemic Control - ADA Inpatient Glycemic Control